What about HES in burn patients?: Evaluation of the actual evidence

Publication date

2018-05-22T12:49:53Z

2019-05-31T05:10:12Z

2018-05

2018-05-22T12:49:53Z

Abstract

Following the 2013 alert by the European Medicines Agency (EMA) discouraging the use of hydroxyethyl-starch solutions (HES) in critically ill and burn patients, most specialized units treating burn victims have stopped using HES in this population. But, how well-founded was the EMA alert in this specific type of patient? ...

Document Type

Article


Accepted version

Language

English

Publisher

Elsevier B.V.

Related items

Versió postprint del document publicat a: https://doi.org/10.1016/j.burns.2017.09.023

Burns, 2018, vol. 44, num. 3, p. 489-493

https://doi.org/10.1016/j.burns.2017.09.023

Recommended citation

This citation was generated automatically.

Rights

cc-by-nc-nd (c) Elsevier B.V., 2018

http://creativecommons.org/licenses/by-nc-nd/3.0/es